Synopsys, Inc. $SNPS Stake Lifted by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA grew its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 90.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,132,130 shares of the semiconductor company’s stock after acquiring an additional 538,737 shares during the period. Pictet Asset Management Holding SA owned about 0.59% of Synopsys worth $492,223,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of SNPS. Elevation Wealth Partners LLC raised its holdings in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. North Dakota State Investment Board grew its holdings in Synopsys by 0.5% during the third quarter. North Dakota State Investment Board now owns 5,706 shares of the semiconductor company’s stock valued at $2,482,000 after purchasing an additional 29 shares during the period. Oak Grove Capital LLC increased its position in Synopsys by 1.1% in the third quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock worth $1,260,000 after buying an additional 32 shares during the last quarter. Kintegral Advisory LLC increased its position in Synopsys by 0.6% in the third quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after buying an additional 32 shares during the last quarter. Finally, Centaurus Financial Inc. increased its position in Synopsys by 2.6% in the first quarter. Centaurus Financial Inc. now owns 1,434 shares of the semiconductor company’s stock worth $569,000 after buying an additional 36 shares during the last quarter. 85.47% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Mizuho dropped their price target on Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a research report on Thursday, August 27th. Robert W. Baird upgraded Synopsys from a “neutral” rating to an “outperform” rating and increased their price target for the stock from $558.00 to $560.00 in a research note on Thursday, August 27th. Needham & Company LLC boosted their price target on shares of Synopsys from $580.00 to $620.00 and gave the company a “buy” rating in a research report on Monday, October 12th. Roth Capital upgraded shares of Synopsys to a “buy” rating in a research note on Friday, September 25th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Synopsys from $650.00 to $600.00 in a report on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $575.00.

Insider Activity

In other Synopsys news, insider Janet Lee sold 1,144 shares of the firm’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the completion of the transaction, the insider directly owned 16,534 shares of the company’s stock, valued at $8,308,665.68. This trade represents a 6.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the business’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the transaction, the chief financial officer owned 22,717 shares of the company’s stock, valued at $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 117,163 shares of company stock worth $51,366,457. Insiders own 0.56% of the company’s stock.

Synopsys Stock Performance

NASDAQ:SNPS opened at $450.46 on Friday. The business’s fifty day moving average is $441.61 and its 200 day moving average is $442.27. The firm has a market cap of $86.33 billion, a price-to-earnings ratio of 79.59, a PEG ratio of 1.43 and a beta of 1.18. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. Synopsys, Inc. has a 52-week low of $362.55 and a 52-week high of $539.48.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The business had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. During the same quarter in the previous year, the firm earned $3.39 EPS. The company’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts predict that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys announced that its board has initiated a stock buyback plan on Monday, October 5th that allows the company to repurchase $1 billion in outstanding shares. This buyback authorization allows the semiconductor company to purchase up to 1.1% of its shares through open market purchases. Share buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

Synopsys Profile

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.